You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Foundation Medicine could be next hot IPO

As biotechs draw interest, firm could be next rocket-propelled stock

Combine an emerging company at the vanguard of personalized cancer treatment with a white-hot market for biotech IPOs, and you have a recipe for the next rocket-propelled stock.

That is the hope for Foundation Medicine of Cambridge, a supplier of genomic testing for cancer patients that filed plans Tuesday with regulators to raise $86.25 million by going public.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week